LY-411575 10mg 10mg | Purity Not Available
Adooq Bioscience
LY-411575 is a selective, cell permeable, small molecule gamma secretase inhibitor.
More Information Supplier PageSearch Results
GSK1838705A 50mg 50mg | Purity Not Available
Adooq Bioscience
GSK1838705A is a small-molecule kinase inhibitor that inhibits IGF-IR and the insulin receptor with IC50s of 2.0 and 1.6 nmol/L, respectively.
More Information Supplier PageGSK1838705A 5mg 5mg | Purity Not Available
Adooq Bioscience
GSK1838705A is a small-molecule kinase inhibitor that inhibits IGF-IR and the insulin receptor with IC50s of 2.0 and 1.6 nmol/L, respectively.
More Information Supplier PageKX2-391 10mM * 1mL in DMSO 10mM * 1mL in DMSO | Purity Not Available
Adooq Bioscience
KX2-391 is a novel non-ATP competitive substrate-pocket directed SRC inhibitor.
More Information Supplier PageKX2-391 5mg 5mg | Purity Not Available
Adooq Bioscience
KX2-391 is a novel non-ATP competitive substrate-pocket directed SRC inhibitor.
More Information Supplier PageNSC-207895 5mg 5mg | Purity Not Available
Adooq Bioscience
NSC207895 is a cell-permeable benzofuroxan compound that downregulates the p53 negative regulator MDMX protein level in MCF-7, LNCaP, and A549 cells (1 to 10 µM for 16 to 24 h) by suppressesing MDMX promoter transcription activity (IC50 = 2.5 µM in HT1080 cells), leading to enhanced p53 stabilization and activation.
More Information Supplier PageNSC-207895 100mg 100mg | Purity Not Available
Adooq Bioscience
NSC207895 is a cell-permeable benzofuroxan compound that downregulates the p53 negative regulator MDMX protein level in MCF-7, LNCaP, and A549 cells (1 to 10 µM for 16 to 24 h) by suppressesing MDMX promoter transcription activity (IC50 = 2.5 µM in HT1080 cells), leading to enhanced p53 stabilization and activation.
More Information Supplier PageNSC-207895 10mg 10mg | Purity Not Available
Adooq Bioscience
NSC207895 is a cell-permeable benzofuroxan compound that downregulates the p53 negative regulator MDMX protein level in MCF-7, LNCaP, and A549 cells (1 to 10 µM for 16 to 24 h) by suppressesing MDMX promoter transcription activity (IC50 = 2.5 µM in HT1080 cells), leading to enhanced p53 stabilization and activation.
More Information Supplier PageBRL-15572 50mg 50mg | Purity Not Available
Adooq Bioscience
BRL-15572 is a selective h5-HT1D antagonist, displaying 60-fold selectivity over h5-HT1B, and exhibiting little or no affinity for a range of other receptor types.
More Information Supplier PageBRL-15572 5mg 5mg | Purity Not Available
Adooq Bioscience
BRL-15572 is a selective h5-HT1D antagonist, displaying 60-fold selectivity over h5-HT1B, and exhibiting little or no affinity for a range of other receptor types.
More Information Supplier Page